Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
Class II · Ongoing
CGMP Deviations
Advertisement
Advertisement
Affected lots / codes — check yours against thisLot # PA02216; Exp. 12/2029
- Recalling firm
- Ajanta Pharma USA Inc, Bridgewater, NJ
- Classification
- Class II (temporary or reversible harm possible)
- Status
- Ongoing
- Quantity
- 3648 bottles
- Distribution
- U.S. Nationwide
- Recall initiated
- May 28, 2026
- Classified
- June 22, 2026
- Initiation
- Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA
enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0611-2026%22
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0611-2026%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots
above against your own product. This page reproduces public FDA data for readability;
EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →